Chapter six hundred and seventeen: characters across the ages
These few months are the most epoch-making months in the history of the anorectal development of the world.
In the past few months, papers with high impact factors have been constantly refreshing the covers of major journals, and to no one's surprise, papers from the clinical trial base of China's Puze Hospital accounted for the majority.
Is bowel cancer about to be solved?
This issue continues to be discussed crazily in major media and websites!
Since the end of the first phase of clinical trials, major data have been analyzed and coordinated, and articles have been published. From that time on, people finally saw the efficacy of this drug.
The trade name of this drug was officially determined after the end of the first phase of clinical trials. It is called Puxikang. The name has no special meaning. It was just an idea that Bai Ye came up with. It could also be called Pudongkang.
I can’t complain about the name...
However, regardless of the name, the drug has completed three phases of clinical trials and has been welcomed by countless countries.
Companies that were originally waiting and watching came to visit again and again, hoping to complete negotiations with Bai Ye.
The deputy general manager of Pfizer also came to China in person in order to cooperate openly with Bai Ye and others. Pfizer meant to directly purchase the patent rights of the drug.
But the price is certainly not low!
This is a drug full of epoch-making significance, and its emergence means the complete cure of tumors!
This sentence feels a bit weird when I say it.
Can tumors be treated?
It couldn't be done before!
But now, it is possible!
There are many causes of intestinal cancer, and Puxicon mainly treats a mainstream type of intestinal cancer, which is also the most common intestinal cancer disease at present.
For a time, the "New England Journal of Medicine", "The Lancet", "Cell"... and many other journals in the medical field were filled with articles about the research process of Puxicon, and even continued to assert that it would be called this.
A great medical turning point in history.
Not only that, the editor-in-chief of the New England Journal of Medicine publicly wrote: "Tumor is currently the biggest enemy of human health, bar none! The emergence of Puxicon is not just a cure for a disease, but the arrival of an era.
The battle against tumors will officially begin today. I believe that there will be countless miracles in the future, and Bai Ye is the one who will open a chapter in history!"
At this time, after the publication of the New England Journal of Medicine, Bai Ye's face was printed on the cover of the New England Journal of Medicine. He is completely different now. The New England Journal of Medicine is the most influential person in the current medical field in the world.
The journal with the highest factor, and The Lancet, has become the gold standard of medicine.
Because The Lancet often participates in discussions of current affairs and politics, the New England Journal of Medicine has become the journal that is most devoted to medicine.
Being recognized by this magazine means that your medical attainments have been recognized by the medical community around the world.
And if you can be on the cover of this magazine, congratulations, your Nobel Prize is gone!
No doubt!
This is the truth!
The New England Journal of Medicine indeed has such great charm and strength.
The Nobel Prize in Physiology or Medicine is awarded every year, and there is more than one. However, there may not be one on the cover of this magazine every few years. Everyone who is on the cover is a person who has made outstanding contributions to medicine.
Compared with the New England Journal of Medicine, this time The Lancet's promotion and praise of Proxicon can be described as exaggerated. It is not an exaggeration to say that he is unscrupulous.
"The Lancet" is so daring to love and hate!
The advent of Puxikan no longer just represents the update of a drug. On the contrary, it means the refresh of an era, the birth of an industrial chain and the decline of another module.
Life is actually a survival game, survival of the fittest.
With the start of these high-scoring medical journals, other small journals have started to swipe and dominate the screen.
In this era of intense publicity, if you are not afraid of having a dark alley, you are just afraid that your wine will be weak.
As long as you have strength, your ability and influence will be infinitely expanded. How big will it be?
It’s so big that you can’t even recognize yourself, it’s so big that you swell!
Therefore, there are countless people who reach the top and then fall to the bottom. This is because they do not recognize themselves well enough.
As for Bai Ye, this time, no matter how exaggerated it is, because the movement this time was really too big.
The birth of a drug means the decline of a disease, and the salvation of the hopes and lives of countless patients. This is a merit!
Bai Ye is the team leader and leader this time, and is even the main developer of the drug Puxicon, but the role of other people is also indispensable.
Bona, Considine, John and others once again received attention.
Considine was very happy. He specially treated everyone to a big meal, opened a bottle of expensive red wine, and gave everyone a precious gift.
At the dinner table, Considin, who was already tipsy, said with a smile: "This time with the emergence of Puxicon drug, I show up again, and my group's stock has been rising in the past few days, Xiaoye, I have to thank you very much."
Fan, you are my rich man! If you have any research in the future, feel free to invite me, as long as you make me famous by the way."
Old Man Considing's words made Bai Ye suddenly realize. He took out his phone and dialed Boss Bai: "Hello? Old Bai, can I talk to you?"
"Oh? You, it's inconvenient, hang up if you have nothing to do." Bai Donglin seemed to be busy and was about to hang up the phone immediately.
Bai Ye: "...Has our stock price gone up?"
Bai Donglin was stunned: "Why hasn't it gone up! Now there are rumors that Puxi Kang will enter the Donglin Group. Now our stock has reached the point where it is hard to get a single vote, and the price is reaching a new high every day! I have already received ten orders.
I got calls from several investment companies.”
Bai Ye lowered his voice and asked, "How much is it now?"
Bai Donglin: "68 US dollars!"
Bai Ye was stunned for a moment!
$68!
It’s doubled!
Compared with the initial listing craze, it has doubled!
This is a little scary.
Bai Ye secretly calculated in his mind that his assets had doubled...
However, it seems that I don’t want Puxi Kang to enter the Donglin Group, right?
The Check and Balance Group is currently planning to go public and is short of a popular product for listing, and Puxicon seems to be a good choice.
However, this time, Bai Ye did not hold the patent for Puxicon alone. Bona, Considine, John, Morstan, and Liu Yue from Boston all had certain proportions.